Mark Abzug, MD
Pediatric Infectious Diseases
Locations
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
720-777-1234
Provider Expertise
Clinical Interest for Patients
I am interested in Perinatal Infection, Enterovirus Infections and Infections in Immunocompromised Patients.
Specialties
- Pediatrics ( 1986 )
- Pediatric Infectious Diseases ( 1994 )
Conditions & Treatments
-
Infections
Viral
-
Immune System
AIDS, AIDS / HIV Disease, AIDS Immunization
Education & Training
Medical Schools
MD, Boston University School of Medicine (1982)
Internships
Strong Memorial Hospital of the University of Rochester Program (1983)
Residency Program
Strong Memorial Hospital of the University of Rochester Program (1985)
Fellowships
University of Colorado (University Hospital) Program (1988)
Professional Memberships
American Academy of Pediatrics (AAP), Member
American Board of Pediatrics Subboard of Pediatric Infectious Diseases Self-Assessment Team, Member
Pediatric Infectious Disease Society, Member
Society For Pediatric Research (SPR), Member
Research & Grants
Research Interests for Patients
Dr. Abzug directs clinical research on patients with viral infections, infections in immunocompromised patients, and pediatric HIV infection. He is involved in national collaborative clinical trials of antiviral therapies, including studies of the National Institutes of Health Collaborative Antiviral Study Group and the National Institutes of Health International Maternal Pediatric Adolescent AIDS Clinical Trials Network.
information for referring providers
Referral Contact Phone
(720) 777-6981
Clinical Interests for Referring Providers
I am interested in Perinatal Infection, Enterovirus Infections and Infections in Immunocompromised Patients.
Research Interest for Referring Providers
Dr. Abzug directs clinical research on patients with viral infections, infections in immunocompromised patients, and pediatric HIV infection. He is involved in national collaborative clinical trials of antiviral therapies, including studies of the National Institutes of Health Collaborative Antiviral Study Group and the National Institutes of Health International Maternal Pediatric Adolescent AIDS Clinical Trials Network.
